1. Introduction {#s0005}
===============

Gene expression analysis captures a snapshot of cellular activity that reflects the response to genetic, environmental and epigenetic changes in a biological system. Determining phenotypes at the molecular level with differentially-expressed genes, using high-throughput technologies such as microarray and next-generation RNA-sequencing (RNA-seq), could help bridge the current gap between genotypes and phenotypes [@bb0005]. Neonatal dried blood spots (DBS) represent a unique biospecimen resource that can provide the "baseline" gene expression at birth for genotype-phenotype studies. In many developed countries, DBS are routinely collected on standard Guthrie cards for newborn screening to diagnose inborn errors of metabolism, hypothyroidism and other diseases [@bb0010]. Post-diagnostic gene expression analysis of DBS can potentially give insights into the cellular response of molecular pathological factors and thereby the etiology of a specific disease. For example, it has been shown that microarray gene expression profiles from DBS can predict children with cerebral palsy [@bb0015].

Denmark has an all-comprising comprehensive system of registries which hold and collect information on social and health related life events for each resident linked through a unique person identifiable number (CPR number) [@bb0020], [@bb0025], [@bb0030]. Since the early 1980s, the Danish Neonatal Screening Biobank (DNSB) has been systematically collecting and storing surplus DBS from the neonatal screening program. While the primary purpose of DBS is to diagnose and treat congenital disorders, it can also be used for research purposes with appropriate approval [@bb0035], [@bb0040]. Several methods have been developed, primarily concerned with utilizing DNA from DBS [@bb0045], [@bb0050], [@bb0055], [@bb0060]. In addition, we and several other groups have shown the feasibility of obtaining RNA and generating RNA gene expression microarray data from DBS for various studies [@bb0015], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090], [@bb0095].

RNA microarray technologies are fast, robust and relatively inexpensive. However, they have inherent problems such as differing hybridization properties of probes, as well as predominant probe placements near the 3′ end of transcripts. RNA-seq, a cutting-edge massively parallel next-generation sequencing technique, has the capacity to sequence each transcript on a single nucleotide basis. While above median transcripts are generally reliably detected by both RNA microarrays and RNA-seq, RNA-seq offers several significant advantages over microarray such as the capability to distinguish isoforms, call sequence variants, and provide improved accuracy for low-abundance transcripts [@bb0100], [@bb0105], [@bb0110]. However, the nature of total RNA, from blood in particular, does complicate sequencing approaches. Firstly, approximately 80% of total RNA from any tissue source is ribosomal RNA (rRNA). Thus, rRNA is usually reduced or removed prior to RNA-seq [@bb0115], [@bb0120]. Secondly, in blood, 50--90% of mRNA transcripts are globin species [@bb0105], [@bb0125]; globin may contribute to uninformative reads that are present in high abundance thus compromising RNA-seq analysis. Globin depletion can remove \~ 80% of globin species, improve correlation of technical replicates, and enable an additional 3500 RNA transcripts to be detected [@bb0105]. In neonatal DBS, globin is primarily derived from fetal hemoglobin (HbF), the predominant form of hemoglobin in the developing fetus which persists in newborn blood until gradually switching over to adult hemoglobin (HbA) \~ 6 months post-birth [@bb0130], [@bb0135]. HbF could be depleted using the same methodology as HbA, but it remains untested whether sequence similarity is high enough to use the exact same method.

To date, RNA-seq for neonatal DBS has not been reported. Here, we conducted a proof-of-concept study to demonstrate the feasibility of obtaining robust and biologically-relevant gene expression data from DBS using RNA-seq.

2. Methods {#s0010}
==========

2.1. DBS samples {#s0015}
----------------

This study does not constitute a health-related research project as defined by the Danish "Act on Research Ethics Review of Health Research Projects". It is considered a developmental project for the Newborn Screening Program instead which does not require a separate approval from the Committees on Biomedical Research Ethics for the Capital Region of Denmark. In this study, we used a set of anonymized neonatal DBS samples that had been stripped of all information including the year of sampling. Sexes were determined using Sequenom\'s Sample ID panel (data not included). Sample names are PKU_M\_0 to PKU_M\_4 for five male DBS and PKU_F\_0 to PKU_F\_4 for five female DBS.

2.2. RNA isolation, library preparation and sequencing {#s0020}
------------------------------------------------------

Total RNA from two 3.2 mm DBS punches was extracted, purified and concentrated using Illustra RNAspin mini (GE Healthcare) and then subjected to DNase treatment to eliminate DNA contamination. Samples were concentrated using RNA Clean & Concentrator (Zymo Research). Sequencing libraries were prepared according to the standard protocol for the Stranded TruSeq RiboZero-Globin kit (Illumina) which includes Globin and rRNA depletion. RNA was fragmented for 4 min at 94 °C and each library was quantified using the KAPA library quantification kit (KAPA). Libraries were pooled before sequencing with a NextSeq-500 sequencer using NextSeq Control Software v1.3.0 (Illumina) on a high output flow cell (v1) with paired end reads of 76 bp (Illumina). Following sequencing, data was de-multiplexed and converted to FASTQ using bcl2fastq v2.17.1.14 (Illumina).

2.3. Data analysis {#s0025}
------------------

The FASTQ files were processed with the settings described by Trepnell [@bb0140] using Tophat v2.0.13 and Cufflinks v2.2.5. Filtering of genes and visualization of results was performed in cummerBund 2.8.2 [@bb0140] using the commands described by Trepnell [@bb0140] within the supplementary information for that paper. The reference genome and gene annotations used was UCSC HG19 prepackaged and downloaded via iGenomes (Illumina, downloaded June 2014).

3. Results {#s0030}
==========

3.1. Library preparation and sequencing statistics {#s0035}
--------------------------------------------------

More than 325 million reads were generated from the 10 samples. The average reads per sample was 32.7 million ± 18.3 million, with 34.4 million ± 18.7 million for females and 31.1 million ± 20.0 million for males. The read length was 32--75 bp with an average of 74 bp, 91.5% of bases exceeded Q30. Detailed information of each sample\'s preparation and sequencing is shown in [Table 1](#t0005){ref-type="table"}. Variation was observed in the dynamic range of transcript intensities, i.e. fragments per kilobase of transcript per million mapped reads (FPKM). Variance in FPKM was more profound across samples than between the sexes ([Supplementary Fig. 1](#f0015){ref-type="graphic"}).

3.2. Transcript detection {#s0040}
-------------------------

To evaluate transcript detection rates, we limit the read alignment to redundant annotated features (transcripts and non-coding RNA). In total, our reference contained 26,799 features. An average of 64% of all features were detected (SD = 15%, range 32--81%) without FPKM cutoff while the number of detectable features dropped to 18% (SD = 7%, range 3--26%) when FPKM ≥ 1 was applied.

To test for potential outliers, dimensional reduction analysis with Multi-Dimensional Scaling (MDS) and Principle Component Analysis (PCA) were used. Both MDS and PCA exhibited two same potential outliers PKU_M\_3 and PKU_F\_1, with MDS showed a potential third outlier PKU_M\_0 ([Supplementary Fig. 2](#f0020){ref-type="graphic"}). We did not exclude the outliers from subsequent analysis of differential expression analysis based on sexes.

3.3. Differentiation of sex-specific gene expression {#s0045}
----------------------------------------------------

To verify whether DBS can reveal biologically-relevant gene expression using RNA-seq, we evaluated a gene set (19 sex chromosome-linked genes; 21 features) identified by the Genotype-Tissue Expression (GTEx) consortium [@bb0145] that are differentially-expressed between male and female in blood. Hierarchical clustering from FPKM showed complete separation of males from females ([Fig. 1](#f0005){ref-type="fig"}A). Gene expression heat map showed female samples expressed only X chromosome-linked genes (*XIST* and *TXLNG*) and none of Y chromosome-linked genes while male samples expressed \> 50% of Y chromosome-linked genes ([Fig. 1](#f0005){ref-type="fig"}B). FPKM values for each sex-specific gene are shown in [Supplementary Table 1](#f0015){ref-type="graphic"}.

3.4. Effect of globin depletion {#s0050}
-------------------------------

In this study, although the exact efficiency of globin depletion is unquantifiable, our results showed that globin did not represent the majority of transcripts. To access the effect of globin depletion on RNA-seq data, FPKM values of eight hemoglobin transcripts (*HBBP1*, *HBG1*, *HBG2*, *HBE1*, *HBZ*, *HBM*, *HBA1* and *HBQ1*) were used to create hierarchical clustering and heatmaps. PKU_M\_1 has higher FPKM values for *HBG1* and *HBG2* when compared with the rest of the samples. Interestingly, by using the entire hemoglobin gene set in the analysis, female samples can be discriminated from male ([Fig. 2](#f0010){ref-type="fig"}A and B). However, when *HBA1* is removed from the analysis, sexes of the samples could not be differentiated ([Fig. 2](#f0010){ref-type="fig"}C and D). Analysis using the full set of transcripts separated the three previously identified outliers into another cluster ([Fig. 2](#f0010){ref-type="fig"}E). FPKM values for hemoglobin transcripts are shown in [Supplementary Table 2](#f0020){ref-type="graphic"}.

4. Discussion {#s0055}
=============

Our results show that we can perform RNA-seq on archived DBS samples, despite having some outliers in the dimensional reduction analysis. Sufficient data can be generated for hypothesis driven research such as gender differentiation shown in this study (gender were correctly called 10 out of 10). Thus, it is feasible to perform RNA-seq on neonatal DBS for transcriptome study shortly after birth. While some biological questions can be answered with DNA sequencing, other inquiries such as pathway analysis for specific disease as demonstrated by Ho et al. in cerebral palsy shows gene expression studies n DBS can contribute to new knowledge [@bb0015].

RNA input for our library preparation was restricted to two 3.2 mm DBS punches for each sample. This imposed limitation is not an arbitrary decision as it reflects what is typically granted by the DNSB steering committee. The steering committee sets this limitation in order to ensure sample availability for the primary purpose of diagnostics, but also availability for future research projects. The amount of total RNA from two punches of 3.2 mm DBS ranges from \< 0.2 ng to 1 μg while the Ribo-Zero Globin reduction kit calls for 100 ng to 1 μg from either fragmented or intact total RNA input to enhance transcript coverage. Consequently, some of the preparations yielded less than the required library output before sample pooling. In cases with low library output, we used all available material and accepted a reduction in the expected read count. Thus, the RNA-seq read counts varied among individual samples. However, the read count difference is negligible when comparing group averages, as shown by 34 million and 31 million reads for females and males respectively.

Here, we detected an average of 65% annotated features (genes and non-coding RNA) at an average reads count of 32.7 million in 10 DBS samples. With FPKM ≥ 1, the number of detectable features was reduced to 18% compared with 33% in a previous study using globin reduction in human blood with \~ 30 M mapped reads [@bb0105]. A study on mouse Th2 cells reported \~ 70% detected genes at \~ 25 million reads when there is no FPKM cutoff [@bb0150]. This suggests that the number of annotated features depends on several factors such as read counts, sample types, and types of organism.

As HbA and HbF are gene complexes, we are unable to quantify their depletion directly. Thus, we evaluated the individual globin subunit transcripts within our dataset instead. While our experiment did not allow us to assess the effectiveness of the depletion directly, we can deduce the globin depletion effect by comparing our data with those in the public datasets. In GTEx, average FPKM values in blood for *HBA1* and *HBA2* are reported at 43,438 and 121,010 respectively. In our study, *HBA1* has an average FPKM of 1318 and *HBA2* is undetected ([Supplementary Table 2](#f0020){ref-type="graphic"}). Thus, the majority of these globin species are been depleted in our study. Interestingly, hierarchical clustering of a globin gene enrichment data set showed two distinct clusters for females and males, driven by *HBA1* ([Fig. 2](#f0010){ref-type="fig"}A and B). When *HBA1* was removed from the analysis, hierarchical clustering and heat map showed a mixture of males and females ([Fig. 2](#f0010){ref-type="fig"}C and D). This observation is in concordance with a study which suggested that sex-associated factor may affects globin switching from HbF to HbA, showing HbA concentration differed significantly between female and male newborns [@bb0155]. A mixture of female and male clusters is also shown when using the entire gene set (unfiltered) ([Fig. 2](#f0010){ref-type="fig"}E). In addition, others have also shown that globin depletion does not introduce significant bias in biological and technical replicates [@bb0105]. This finding further support the feasibility of using DBS to detect reliable biologically-relevant gene expression.

Our experimental design was intended to be simple and hypothesis driven, since the inference we wish to draw upon in this proof-of-principle study is that if we can determine sex, then other biologically significant signals could also be detected. We chose to maintain this simplicity by strictly following the established RNA-seq data analysis pipeline published by Tranell et al. [@bb0140], thereby applying an established approach and avoid arbitrary decision bias of the findings. When enriching our dataset with sex-specific transcripts in blood determined by GTEx, we are able to distinguish females from males in the DBS samples, as presented by hierarchical clustering and heat map in [Fig. 1](#f0005){ref-type="fig"}. The separation of female from male cluster is close to 1, indicating a near complete segregation which agrees with the sex call from the Sequenome Sample ID panel (data not shown). However, not all sex-segregating transcripts are consistently expressed at detectable levels ([Supplementary Table 1](#f0015){ref-type="graphic"}). The exact reason is unclear. One explanation can be the age difference between the GTEx cohort and DBS samples: DBS are taken from newborns while GTEx samples are taken from post-mortem donors aged 21--70 [@bb0160], [@bb0165]. Despite some discordance with the GTEx data, there are a number of relevant candidate genes for sex determination in neonatal samples within the GTEx sex-specific set. From [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, as well as [Supplementary Fig. 1](#f0015){ref-type="fig"}, [Supplementary Fig. 2](#f0020){ref-type="fig"}, we found the expression of *LINC00278*, *EIF1AY*, *UTY* and *RPS4Y1* unique in males, while *XIST* and *HBA1* are unique in females. These genes are suitable to determine sex in DBS.

In addition to laboratory research applications, DBS technology can be expanded to patients of any age as a standard blood collection to simplify clinical procedures. Depending on the purpose of clinical visitation, DBS can be drawn from a finger in the patient\'s own home to reduce or eliminate frequent visits to the clinic. It would also minimize the discomfort to a prick in the finger compared to a standard blood draw. DBS may also facilitate clinical diagnosis. For example, fetal hypoxia that leads to more than a million stillbirths worldwide each year can be diagnosed with the presence of fetal induced hypoxia but requires multiple testing at multiple times [@bb0170], [@bb0175]. DBS can be collected at multiple times with minimum stress to measure hypoxia-induced RNA and identify critically hypoxic fetuses in utero. There is also a potential to collect blood as DBS samples in poor-resourced clinical settings as this methodology greatly simplifies the logistics and reduce processing costs. It has been recommended to perform microarray differentially gene expression analysis from DBS stored at ambient temperature within 6 years while there is no gene expression difference between samples stored at 10 years apart at − 20 °C. However, the effects of storage time and temperature on RNA-seq data obtained from DBS is currently unknown and warranted future investigation [@bb0080], [@bb0180].

In conclusion, this proof-of-concept study demonstrated the feasibility to obtain reliable gene expression from DBS using RNA-seq. It is also feasible to use globin depletion protocols intended for adult hemoglobin for fetal globin depletion in DBS. Sex can be differentiated from DBS and a combination of six transcripts: *LINC00278*, *EIF1AY*, *UTY*, *RPS4Y1*, *XIST* and *HBA1* allowed high confidence of sex determinations. We can also determine novel biological changes such as differences in HbA levels between males and females. This newly established RNA-seq assay for DBS will enable high- throughput molecular epidemiology and diagnostic studies to better understand various perinatal diseases.

The following are the supplementary data related to this article.Supplementary Fig. 1A) Group level FPKM box plots. B) Sample level FPKM box plots. C) Group level density plot. D) Sample level density plot. Variation exists within the generated data set especially at the level ofindividual samples. Looking at the group level performance is homogenous with average read counts of 34.4 ± 18.7 million and 31.1 ± 20.0 million (Mean ± SD), respectively for female and male.Supplementary Fig. 1Supplementary Fig. 2Based on the gene level data we calculated A) Multi-Dimensional Scaling B) Principle component analysis. Both dimensional reductions agree that PKU_M\_3 and PKU_F\_1 are outliers. PKU_M\_0 is an outlayer but unique to A.Supplementary Fig. 2Supplementary Table 1FPKM values per gene. This geneset has been identified by the GTEx consortium as being differentially expressed between the sexes in blood.Supplementary Table 1Supplementary Table 2Table of FPKM values for hemoglobin genes.Supplementary Table 2
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![A) Hierarchical clustering of FPKM values based on differentially-expressed genes between males and females in blood genes identified by the GTEx consortium. B) Heatmap of FPKM values based on differentially-expressed genes between males and females in blood genes identified by the GTEx consortium.](gr1){#f0005}
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###### 

RNA input and RNA-seq data of 10 dB (5 females and 5 males).

Table 1

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sample ID   Input RNA\   Read length range\   Average read length\   Raw bases Q10 +\   Raw bases Q20 +\   Raw bases Q30 +\   Read count   Total sequence generated\
              (ng)         (bp)                 (bp)                   (bp)               (bp)               (bp)                            (bp)
  ----------- ------------ -------------------- ---------------------- ------------------ ------------------ ------------------ ------------ ---------------------------
  PKU_F\_0    314          32--75               74.51                  99.99              99.75              93.18              41,164,517   3,067,015,571

  PKU_F\_1    70           32--75               74.48                  99.99              99.52              93.64              49,891,753   3,715,888,452

  PKU_F\_2    40           32--75               74.57                  99.98              99.74              93.99              47,901,645   3,571,868,192

  PKU_F\_3    40           35--75               74.41                  99.87              99.42              89.84              28,409,088   2,113,940,315

  PKU_F\_4    \< 0.2       35--75               63.65                  76.11              51.85              44.73              4,520,783    287,745,978

  PKU_M\_0    60           32--75               74.48                  99.99              99.68              93.28              45,422,192   3,382,887,870

  PKU_M\_1    500          32--75               74.51                  99.99              99.81              94.51              19,988,616   1,489,344,449

  PKU_M\_2    1000         35--75               74.44                  99.88              99.44              88.95              58,476,079   4,352,678,456

  PKU_M\_3    1000         35--75               74.54                  99.96              99.48              89.81              20,580,446   1,533,986,335

  PKU_M\_4    1000         35--75               74.54                  99.97              99.48              89.82              10,949,721   816,165,766
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
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